|
Atomistry » Fluorine » PDB 4c6l-4cqj » 4ccb | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4c6l-4cqj » 4ccb » |
Fluorine in PDB 4ccb: Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-AmineEnzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine
All present enzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine:
2.7.10.1; Protein crystallography data
The structure of Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine, PDB code: 4ccb
was solved by
M.Mctigue,
Y.Deng,
W.Liu,
A.Brooun,
A.Stewart,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine
(pdb code 4ccb). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine, PDB code: 4ccb: Fluorine binding site 1 out of 1 in 4ccbGo back to Fluorine Binding Sites List in 4ccb
Fluorine binding site 1 out
of 1 in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine
Mono view Stereo pair view
Reference:
Q.Huang,
T.W.Johnson,
S.Bailey,
A.Brooun,
K.D.Bunker,
B.J.Burke,
M.R.Collins,
A.Cook,
J.J.Cui,
K.N.Dack,
J.G.Deal,
Y.Deng,
D.M.Dinh,
L.D.Engstrom,
M.He,
J.Hoffman,
R.L.Hoffman,
H.Shen,
P.Johnson,
R.S.Kania,
H.Lam,
J.L.Lam,
P.Le,
Q.Li,
L.Lingardo,
W.Liu,
M.West Lu,
M.A.Mctigue,
C.L.Palmer,
P.F.Richardson,
N.W.Sach,
T.Smeal,
G.L.Smith,
A.E.Stewart,
S.L.Timofeevski,
K.Tsaparikos,
H.Wang,
H.Zhu,
J.Zhu,
H.Y.Zou,
M.Edwards.
The Design of Potent and Selective Inhibitors to Overcome Clinical Alk Mutations Resistant to Crizotinib. J.Med.Chem. V. 57 1170 2014.
Page generated: Sun Dec 13 12:00:23 2020
ISSN: ISSN 0022-2623 PubMed: 24432909 DOI: 10.1021/JM401805H |
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |